CAS: 204656-20-2
Purpose: As a classic long-acting GLP-1 receptor agonist API, liraglutide is widely used in the development and manufacture of formulations for glycemic control in type 2 diabetes mellitus as well as weight management therapies for obesity and overweight. It is also suitable for the development of adjunctive therapies targeting metabolic syndrome and insulin resistance, serving as a key active pharmaceutical ingredient for clinically essential metabolic therapeutics.
Formula: C172H265N43O51

CAS: 2381089-83-2
Purpose: Suppresses the hypothalamic appetite center, delays gastric emptying to reduce caloric intake, and activates lipolysis to increase whole-body energy expenditure, thereby promoting fat burning.
Formula: C221H342N46O68

CAS: 910463-68-2
Purpose: Indicated for the management of type 2 diabetes mellitus and obesity.
Formula: C187H291N45O59

CAS: 2023788-19-2
Purpose: Delays gastric emptying, suppresses appetite, stimulates insulin secretion, and inhibits glucagon release. Through the synergistic activation of GLP-1 and GIP pathways, it enhances glycemic control, promotes weight reduction, and improves insulin sensitivity—benefits that cannot be achieved through the GLP-1 pathway alone.
Formula: C225H348N48O68

CAS: 1143516-05-5
Purpose: Indicated for patients with Duchenne muscular dystrophy (DMD) amenable to exon 51 skipping. By promoting exon skipping during pre-mRNA splicing, it restores partial dystrophin production, helping to slow muscle degeneration and delay disease progression. It is not a curative therapy and must be administered by intravenous infusion.
Formula: C4H12N2O

CAS: 305-84-0
Purpose: Exhibits anti-inflammatory, anti-glycation, antioxidant, and chelating properties.
Formula: C9H14N4O3

CAS: 1491144-00-3
Purpose: A complement component C5 inhibitor primarily indicated for the treatment of geographic atrophy (GA) secondary to age-related macular degeneration (AMD).
Formula: ——

CAS: 1173755-55-9
Purpose: Treats exon 51 deletion in dystrophin, for DMD
Formula: C364H569N177O122P30

CAS: 1422959-91-8
Purpose: Indicated for the treatment of Duchenne muscular dystrophy (DMD).
Formula: ——

CAS: 937402-51-2
Purpose: Enhances vaccine efficacy and promotes antiviral and antitumor immune responses.
Formula: ——

CAS: 332437-00-0
Purpose: Exhibits potent immunomodulatory and immune-activating properties, with applications including vaccine adjuvants, antiviral therapies, and cancer immunotherapy.
Formula: ——

CAS: 455348-63-7
Purpose: An immunostimulant that enhances vaccine efficacy, strengthens anti-infective immune responses, and supports immune modulation.
Formula: ——